Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Samsung BioLogics, Roche Sign Strategic Manufacturing Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Samsung BioLogics, Roche Sign Strategic Manufacturing Pact

To manufacture Roche’s commercial biologics at Incheon facilities

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Samsung BioLogics and F. Hoffmann-La Roche have entered into a long-term strategic manufacturing agreement under which Samsung will manufacture Roche’s commercial biologic medicines at its two manufacturing facilities in Incheon, South Korea. One of the facilities is currently under construction. Financial terms and products under the agreement were not disclosed.
 
“We are pleased to announce this strategic manufacturing relationship with Roche and look forward to delivering best-in-class manufacturing services with the highest global quality standards,” said Tae-Han Kim, president and chief executive officer of Samsung BioLogics. “This collaboration with the world’s largest biotech company is an important milestone for Samsung as it validates our long term strategy of becoming a leader in biopharmaceutical manufacturing.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics